摘要
甲亢性骨质疏松是因甲状腺激素过多引起机体骨代谢及骨矿化紊乱而导致的继发性疾病,随着社会的节奏不断加快,其发病率也逐年升高。因其沉默性发病,临床上常常出现漏诊、误诊,耽误了治疗的最佳时机,使病情加重,病程延长,故早诊断、早治疗是治疗此病的关键。对于其治疗,现代医学尚无明确治疗方案和早期干预手段,中医药治疗甲亢性骨质疏松具有充分优势,《黄帝内经》认为“肝藏血主疏泄,调畅气机,以强筋骨”,提示气血的运行、筋骨的生长与肝的疏泄功能密切相关。但目前临床治疗多集中在“肾为先天主骨生髓”方面,忽视了“从肝论治”在甲亢性骨质疏松防治中的重要性。本文旨在从中西医角度探讨“从肝论治”甲亢性骨质疏松临床研究的相关性,为甲亢性骨质疏松的防治诊疗提供新思路。
Hyperthyroid osteoporosis is a secondary disease caused by excessive bone metabolism and bone mineralization caused by excessive thyroid hormones.As the pace of society continues to accelerate,its incidence also increases year by year.Because of its silent onset,miss to diagnosis or fail to diagnosis often occurs in the clinic,which delays the best time for treatment,aggravates the disease,and prolongs the course of the disease.Therefore,early diagnosis and treatment are the key to the treatment of this disease.For its treatment,modern medicine does not have a clear treatment plan and early intervention method.Traditional Chinese medicine has sufficient advantage in the treatment of hyperthyroid osteoporosis.Canon of the Yellow Emperor demonstrates that the liver preserves blood,governs dispelling,adjusts Qi,and strengthens bone,suggesting that the operation of qi and blood and the growth of muscle and bone are closely related to dispelling function of the liver.However,the current clinical treatment mostly focuses on that the kidney governs the bone and generates marrow,ignoring the importance of treatment from the liver in the prevention and treatment of hyperthyroid osteoporosis.This article aims to discuss the relevance of clinical research of treatment from the liver for hyperthyroid osteoporosis from the perspective of Chinese and Western medicine,and to provide new ideas for the prevention and treatment of hyperthyroid osteoporosis.
作者
胡飞
李双蕾
宋石开
陈远瑾
覃海恋
胡洲映
HU Fei;LI Shuanglei;SONG Shikai;CHEN Yuanjin;QIN Hailian;HU Zhouying(Guangxi University of Traditional Chinese Medicine, Nanning 530001;The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530023, China)
出处
《中国骨质疏松杂志》
CAS
CSCD
北大核心
2021年第6期906-909,共4页
Chinese Journal of Osteoporosis
基金
国家自然科学基金项目(81860784)
广西名老中医民族医传承工作室建设项目(桂卫中[2014]9号)
广西中医药大学自然科学研究项目(2016QN018)
广西自然科学基金课题(2018GXNSFBA138044)
广西中医基础研究重点实验室资助项目(K201137905)
广西中医药大学第一附属医院青年基金(GZYQJ2014004)。
关键词
甲亢性骨质疏松
从肝论治
中医
肝主疏泄
hyperthyroid osteoporosis
treatment from the liver
Chinese medicine
liver governs dispelling
